Tobacco
We are strengthening our tobacco business, our largest business segment, through international expansion, product brand enhancement, and innovation unfettered by convention.
Our core businesses
While On May 7th, 2025, the Company entering into an agreement with the Shionogi & Co., Ltd. transfer of the pharmaceutical business and our stake in TORII PHARMACEUTICAL CO., LTD.(''Torii'') a consolidated subsidiary, the JT group's performance and initiatives until 2024 described in this summary include those associated with the pharmaceutical business and Torii.
Please see the press release on our website for the details.
Pharmaceuticals
JT is committed to the research and development of world-class, innovative drugs.
Processed food
Our processed food business meet the needs of our consumers with a variety of safe and delicious meal choices.